Chicago, USA
Flashpoint is developing nanotherapeutic candidates that can co-deliver precise RNA, DNA and peptide payloads to the right cells at the right time.
This capability overcomes many major limitations of current therapeutics that have focused on defining potent components but cannot control how they work together. Our new approach to drug discovery can transform therapeutic components from ineffective to curative through optimized nanoscale architecture.
No key contacts have been added to this profile yet.
No reviews have been added to this profile yet.
This is the company profile page for Flashpoint Therapeutics on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.
